OQP BioM Shareholder Alliance: Quest-pharma Tech's Takeover Bid for OQP BioM Faces Scrutiny Amid Accusations and Silence
Article content
YONGIN, South Korea — OQP BioM Shareholder Alliance (represented by Jung-Woo Bae) has voiced criticism against Dr. Madiyalakan's refusal to answer official inquiries from the Alliance and his unilateral claims to the media.
Article content
A takeover bid for the biotech firm OQP BioM by Quest-pharma Tech (QPT) and its leader, Dr. Madiyalakan, is facing a growing storm of controversy and questions regarding his sincerity. The core of the criticism stems from Dr. Madiyalakan's refusal to answer official inquiries from the OQP BioM Shareholder Alliance, while simultaneously making unilateral claims to the media, a move the group denounces as deeply problematic.
Article content
Article content
The Core Criticism: 'A Contradiction for the Man Responsible for Failure to Attempt a Takeover'
Article content
The OQP BioM Shareholder Alliance sent two public letters of inquiry to Dr. Madiyalakan on June 23 and 24. In these letters, the alliance clearly stated its position: the ultimate 'cause' of OQP BioM's recent Phase 3 clinical trial failure lies with Dr. Madiyalakan, the drug's original developer.
Article content
According to the shareholder group, the trial's failure resulted from a fundamental 'flaw in the clinical protocol design.' They argue that the protocol erroneously designated 'Progression-Free Survival (PFS)' as the sole primary endpoint, ignoring the delayed effects characteristic of immunotherapies. The group points to the fact that the Data Safety Monitoring Board (DSMB) had recommended continued observation for 'Overall Survival (OS)' as clear evidence of this design flaw.
Article content
The Alliance argues that for the very person responsible for this failure to not only refuse to accept responsibility but to then use the resulting situation to try and acquire OQP BioM for 15 billion KRW is an act that 'defies common sense and business ethics.'
Article content
In response, the OQP BioM Shareholder Alliance has publicly demanded that Dr. Madiyalakan provide clear answers to three key questions:
Article content
The source and substance of the 15 billion KRW acquisition fund.
A plan for a transparent governance structure, including the potential appointment of a representative from the minority shareholder alliance to the board.
A concrete financing roadmap for the additional up to 50 billion KRW required for CMC (Chemistry, Manufacturing, and Controls) and the completion of clinical trials.
Article content
Evasion and 'Media Ploy' Amplify Doubts
Article content
While remaining silent on these official questions, Dr. Madiyalakan has engaged in media interviews, making claims that the Shareholder Alliance has publicly refuted as 'blatantly false.'
First, the Alliance rejected QPT's claim that it 'was never consulted or notified' regarding OQP BioM's acquisition of ADBIOTECH. The group stated that a director personally appointed by QPT attended the board meeting where the M&A was approved and even exercised voting rights, calling QPT's denial an 'irresponsible disavowal of a decision made by the company's highest governing body.'
Article content
Second, the Alliance dismissed the claim that 'Dr. Madiyalakan, the developer, was excluded from the clinical trial process' as a 'self-contradiction.' They pointed out that the trial was conducted according to the 'completed Phase 3 protocol' that Dr. Madiyalakan himself designed, suggesting this claim is merely a 'preemptive excuse to evade responsibility.'
Article content
The Path to Restoring Trust: Transparency and a Verifiable Plan
Article content
The current actions of Dr. Madiyalakan and QPT do not resemble those of a savior coming to rescue a company in crisis. Instead, they give the impression of a party that is ignoring the company's owners—the shareholders—and attempting to manipulate public opinion with unverified information.
Article content
For the individual identified as most responsible for OQP BioM's major setback, to demand control of the company is a difficult position to defend. The lack of clarity surrounding the acquisition funds and the absence of a plan for future financing only deepens the anxiety.
Article content
If Dr. Madiyalakan is genuinely concerned about the future of OQP BioM, he must break this suspicious silence, and provide responsible, transparent answers to the shareholders' questions. His response will determine whether this takeover proposal is a lifeline for OQP BioM, or a dangerous attempt that plunges the company into even greater chaos. The market and all of OQP BioM's shareholders are watching closely.
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Baidu's AI-Push Gains Momentum: Is ERNIE Enough to Power Ambitions?
Baidu, Inc. 's BIDU push into AI is gaining momentum and the centerpiece of that effort is its ERNIE family of large language models. The latest iterations, ERNIE 4.5 and X1 Turbo, demonstrate remarkable progress in both reasoning and multimodal capabilities. Yet the key question remains: Is ERNIE alone enough to anchor Baidu's broader AI strategy? There is no denying the model's technical strength. ERNIE now powers a growing share of Baidu's product ecosystem, including Gen AI-enhanced search, intelligent digital humans and its Qianfan model-as-a-service platform. These efforts are already translating into commercial success, AI Cloud revenues surged 42% year over year in first-quarter 2025, now accounting for 26% of Baidu Core revenues. However, Baidu's AI strategy is clearly broader than just the ERNIE model itself. The company's strength lies in its end-to-end AI stack, combining infrastructure, models, applications and tools. Importantly, it is adopting an application-driven approach, optimizing model development around real-world use cases, not academic benchmarks. Open-sourcing ERNIE 4.5 later this year indicates Baidu's confidence, but also a strategic hedge. In a fiercely competitive AI landscape, where rivals offer chatbots and foundation models of their own, openness and flexibility can drive developer adoption. So, while ERNIE is the engine, it is Baidu's integrated AI ecosystem, Qianfan, agents, digital humans and Apollo Go, that fuels the real ambition. On its own, ERNIE may not be enough. But as part of Baidu's full-stack AI playbook, this could be more than enough to keep it at the forefront of China's AI race. AI Rivals in Focus: How Baidu's ERNIE Compares to Alibaba and Tencent Baidu's ERNIE may be at the forefront of China's AI-foundation model race, but Alibaba Group Holding Limited BABA and Tencent Holdings Limited TCEHY are formidable challengers building out their own AI ecosystems. Alibaba, through the Cloud Intelligence Group, has been pushing hard with its Tongyi Qianwen model series. Integrated deeply into enterprise SaaS, cloud services and consumer-facing platforms like DingTalk, Alibaba's model strategy emphasizes versatility and ecosystem embedding. The company's enterprise scale and cloud dominance give it distribution power that Baidu must match through Qianfan and strategic partnerships. Tencent, meanwhile, is leveraging its massive user base and gaming, social and content platforms to deploy Hunyuan, its own large model. The company focuses more on AI-as-a-service and verticalized applications across entertainment, finance and healthcare. While Baidu leads in full-stack AI infrastructure, Tencent's reach and monetization pathways pose a real challenge. To stay ahead, Baidu must keep differentiating ERNIE with cost-efficient performance, rapid iteration and real-world applications at scale. BIDU's Price Performance, Valuation and Estimates Baidu's shares have lost 12% in the past three months against the Zacks Internet - Services industry's 5.6% rise. Price Performance BIDU's forward 12-month price/earnings ratio is 8.63, far below the industry average of 18.13. P/E (F12M) Image Source: Zacks Investment Research Over the past 60 days, the Zacks Consensus Estimate for Baidu's 2025 earnings per share has decreased, as you can see below. Baidu currently carries a Zacks Rank #5 (Strong Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Research Chief Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Baidu, Inc. (BIDU): Free Stock Analysis Report Tencent Holding Ltd. (TCEHY): Free Stock Analysis Report Alibaba Group Holding Limited (BABA): Free Stock Analysis Report
National Post
3 hours ago
- National Post
North Korea will open a beach resort with plans to allow foreign visitors
Article content In February this year, a small group of international tourists visited North Korea for the first time in five years, but tourist agencies said in March that their tours to North Korea were paused. Article content Article content Kim's recent foreign policy prioritizes relations with Russia as he's been supplying troops and conventional weapons to support its war against Ukraine in return for economic and military assistance. But North Korea's ties with China, which has long been its biggest trading partner and aid benefactor, have apparently cooled as China is reluctant to join an anti-Western alliance with North Korea and Russia, analysts say. Article content Tuesday's ceremony that marked the completion of the resort's construction drew the Russian ambassador to North Korea and his embassy staff, KCNA said. But it didn't say whether any Chinese diplomats were also invited. Article content 'There seems to be issues that North Korea hasn't yet resolved in its relations with China. But North Korea has put in too much money on tourism and plans to spend more. Subsequently, to get its money's worth, North Korea can't help receiving Chinese tourists,' Lee Sangkeun, an expert at the Institute for National Security Strategy, a think tank run by South Korea's intelligence agency. Article content Lim Eul-chul, a professor at Kyungnam University's Institute for Far Eastern Studies in Seoul, also said that foreign tourism to the Wonsan-Kalma site will begin with Russians. But he said Chinese tours to the zone, a sort of civilian exchange, will also begin soon, adding bilateral trade between China and North Korea has been recovering. Article content Article content Lim said that South Korean and American tours to North Korea won't likely restart anytime soon, though both new liberal South Korean President Lee Jae Myung and U.S. President Donald Trump have expressed hopes to revive dialogue with North Korea. Article content In January when Trump boasted about his ties with Kim, he said 'I think he has tremendous condo capabilities. He's got a lot of shoreline,' a likely reference to Wonsan-Kalma. Article content North Korea hasn't publicly responded to Trump's outreach. It has repeatedly rejected Washington and Seoul's dialogue offers and focused on expanding its nuclear weapons program since Kim's high-stakes nuclear diplomacy with Trump collapsed in 2019. Article content
Globe and Mail
3 hours ago
- Globe and Mail
IBI Announces 23-Fold Surge in Net Profit for FY2025
HONG KONG, Jun 26, 2025 - (ACN Newswire) - IBI Group Holdings Limited (' IBI ' or the ' Company ', together with its subsidiaries, the ' Group '; Stock Code: 1547), a company focused on investments in the built environment, today announced its audited consolidated results for the year ended 31 March 2025 ('FY2025' or the 'year under review'). FY2025 was marked by a challenging global economic environment, which placed significant pressure on the construction industry and resulted in highly competitive tendering conditions. At the same time, global trade tensions triggered unexpected volatility, prompting capital flows to shift towards Asia. This trend has begun to invigorate the Hong Kong market and may help to alleviate some of the pressure on Mainland China's manufacturing sector. Coupled with a strong rebound in inbound tourism and improving market sentiment, these developments have contributed to a more optimistic local outlook. The Group remains confident in Hong Kong's economic prospects and, with its rigorous risk management, effective cost control, and strategic focus on emerging opportunities, is well positioned to navigate the evolving landscape and drive sustainable growth. During the year under review, the Group demonstrated remarkable resilience and delivered a solid financial performance. Profit attributable to the owners of the Company surged around 23.0 times to approximately HK$8.4 million (FY2024: approximately HK$0.4 million). This increase was mainly attributable to improvement in the Building Solutions segment, the recognition of the unrealised profit generated from financial assets at fair value, and the recognition of a significant fair value loss on investment property in the previous year. Basic and diluted earnings per share was HK1.0 cent (FY2024: HK0.0 cents). The Board has recommended the payment of a final dividend of HK0.5 cents for FY2025 (FY2024: HK0.5 cents). Mr. Neil Howard, Chairman and Chief Executive Officer of IBI, said, 'Despite the challenging global economic environment, the Group delivered a strong performance in FY2025, with profitability rising significantly. Furthermore, towards the end of the period, the Group successfully secured four large projects with a total value exceeding the entire turnover for FY2025. This notable result highlights the effectiveness of our strategic focus, the depth of our resilience, and our ability to adapt quickly to change. Looking ahead, we will continue to strengthen our business development, respond swiftly to market dynamics, and pursue continuous improvement to drive long-term value creation and deliver sustainable returns to our shareholders.' Business Review IBI provides world-class interior fitting-out and building refurbishment services in Hong Kong and Macau, predominantly acting as the main contractor for clients across many industry sectors. The construction industry remained under pressure for most of the year. Although the Group completed a higher number of projects compared to the previous period, many were smaller in scale, resulting in a decline in turnover. However, through strict cost control and proactive final accounting by the commercial team, the segment delivered a solid set of results despite the challenging environment. During the year under review, the Group recorded profit from contracting of approximately HK$7.4 million (FY2024: approximately HK$15.2 million), completed 12 projects, and was awarded 13 projects. Notably, during the latter part of the period, the Group secured four large projects with a total value exceeding the entire turnover for FY2025. In May 2025, IBI entered into a memorandum of understanding regarding a potential investment in the development of a new central business district covering around 318 hectares in Manila, the Philippines. Leveraging its expertise in construction and project management, the Group will serve as project advisor, overseeing the project and providing professional advice on construction, procurement, and progress. This collaboration supports the Group's long-term strategy and, if realised, could diversify its income streams and support long-term growth. These projects will lay a strong foundation for FY2026. In Macau, IBI secured its first project since resuming operations. The Group is actively rebuilding relationships with previous clients and aggressively tendering for new projects. Solutions The Group's subsidiary, Building Solutions Limited ('BSL'), which provides products and services that enhance the performance and well-being of the built environment in order to provide modern, healthy and high-performing spaces for occupants, recorded a significant and continued improvement in its performance. During the year under review, BSL recorded a segment profit of approximately HK$0.6 million (FY2024: segment loss approximately HK$0.3 million), with sales revenue increasing by 58.2% year on year. BSL achieved profitability during FY2025, marking a significant milestone for the start-up. With continued research and identification of new products, the Group believes that the division's reputation for delivering high-quality building products and services will achieve further growth. Investments The Group's strategic investment division was established to efficiently allocate capital into new market sectors and expand its presence in the built environment. During the year under review, the strategic investments division of the Group recorded a segment profit of approximately HK$0.9 million (FY2024: segment loss approximately HK$3.2 million), which was realised from an unrealised fair value gain on its investment in a large real estate investment trust, a Hong Kong-listed company that owns and manages a diversified and high-quality portfolio. Regarding the assets in Japan, specifically the plots of land in Kutchan, Hokkaido, the Group is continuing to analyse the optimum strategy for the site, and is considering expanding the project, as the analysis indicates that a larger-scale development could provide significant economies of scale and a far greater return on investment. Moving forward, the Group will continue to explore potential investment opportunities and looks forward to announcing further successes in this area. Investments The Group's property investment subsidiary focuses on purchasing physical real estate to generate additional income and expand the Group's geographical presence. The property investment division of the Group recorded a segment profit of approximately HK$2.5 million for FY2025 (FY2024: segment loss approximately HK$8.1 million), maintaining a steady performance and a 100% occupancy rate. During the year under review, the Group engaged a planning architect to survey the West Wing rooftop area and prepare an initial design for additional commercial space. The Group then held a pre-planning meeting with the local government planning office, which gave positive feedback and indicated that it would not object to the construction of an additional floor. This addition would create 2,500sq ft of tenantable space, which is expected to have a positive impact on the property's valuation. About IBI Group Holdings Limited (stock code: 1547) IBI Group Holdings Limited is a publicly listed holding company on the Hong Kong Stock Exchange, focused on investments in the Built Environment. The Group's investments whilst principally centering around the role of contracting, include businesses providing innovative, high quality manufacturing and supply solutions across a diverse range of the built environment. Our mission is to deliver premium products, services and customer experiences with a strong influence of innovation, sustainability and wellness. For more information, please refer to IBI's website: ]]> Source: IBI Group Holdings Limited Copyright 2025 ACN Newswire . All rights reserved.
